RHB Retail Research
Trading Stocks - Duopharma Biotech
Duopharma Biotech broke out from its multi-session congestion area around the 21-day SMA line on strong volume – indicating the stock may be extending its rebound. A positive bias is expected above MYR3.50, with resistance levels pegged at MYR3.85 and MYR4.15. A downside breach of MYR3.50 would cancel this positive price forecast.
Source: RHB Securities Research - 15 Jan 2021
Related Stocks
| Chart | Stock Name | Last | Change | Volume |
|---|
More articles on RHB Retail Research
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2024-07-17 16:15:00
EMA 5
5 Mins
SELL
2024-07-17 16:10:00
ADX
10 Mins
SELL
2024-07-17 16:10:00
ADX
5 Mins
SELL
2024-07-17 16:10:00
OBV
5 Mins
SELL
2024-07-17 16:00:00
ADX
10 Mins
BUY
Apps
Top Articles
1
The Alpha Trader
2
Bursa Stock Musings - Thoughts & Ideas
PGF Capital - insti shareholding up from 5% to 14%! (part 1)
3
南洋行家论股
4
How to become a resilient trader
5
RHB Investment Research Reports
7
BreakingOut
8
Koon Yew Yin's Blog
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
